CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 233 enrolled
Drug / intervention
TachoSil®other
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01920958
NCT01920958N/ACompleted
CompareCT.gov

Use of Tachosil® for Lymph Sealing During Surgery. A Non-Interventional Study

Takeda·observational·Posted Aug 12, 2013·Updated Dec 19, 2016

In Brief

An observational study evaluating TachoSil® for Lymph Node Resection. Completed, enrolled 233 participants across 1 site.

Detailed Summary

The purpose of this study is to describe effectiveness and reliability of TachoSil® in lymph sealing after lymphadenectomy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsLymph Node Resection
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedAug 12, 2013
Enrollment StartSep 1, 2012
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 12.9 years ago

Interventions

TachoSil®other

TachoSil® is a collagen sponge that is coated with the active substances human fibrinogen and human thrombin and that supports hemostasis and tissue sealing in surgery.